Activation of NF-κB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP+ toxicity in SK-N-SH cells

Journal of Neural Transmission

Volumn 115, Issue 5, 2008, Pages 669-676

  Sarnico, I ^a   Boroni, F ^a   Benarese, M ^a   Sigala, S ^a   Lanzillotta, A ^a   Battistin, L ^b   Spano, P ^a,b   Pizzi, M ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

CHPG; mGlu5 receptor; MPP+; Neuroblastoma; NF B; SK N SH cells

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 CHLORO 5 HYDROXYPHENYLGLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; 2-CHLORO-5-HYDROXYPHENYLGLYCINE; AMINO ACID RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; GLYCINE; HERBICIDE; PHENYLACETIC ACID DERIVATIVE; TRANSCRIPTION FACTOR REL;

APOPTOSIS; ARTICLE; CELL LOSS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL TOXICITY; NEUROPROTECTION; PARKINSONISM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; CELL DEATH; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; METABOLISM; NEUROBLASTOMA; TIME; TUMOR CELL LINE;

1-METHYL-4-PHENYLPYRIDINIUM; ANALYSIS OF VARIANCE; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GLYCINE; HERBICIDES; HUMANS; NEUROBLASTOMA; NF-KAPPA B; PHENYLACETATES; PROTO-ONCOGENE PROTEINS C-REL; TIME FACTORS;

EID: 44749092463     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0007-2     Document Type: Article

References (44)

1. Allen JW, Knoblach SM, Faden AI (2000) Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ 7:470-476
2. Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, Troost D (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci 17:2106-2118
3. +), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP. Life Sci 46:379-390
4. Bao WL, Williams AJ, Faden AI, Tortella FC (2001) Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res 922:173-179
5. Battaglia G, Fornai F, Busceti CL, Aloisi G, Cerrito F, De Blasi A, Melchiorri D, Nicoletti F (2002) Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J Neurosci 22:2135-2141
6. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Storto M, Fornai F, Nicoletti F, Bruno V (2004) Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Neurosci 24:828-835
7. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757
8. Bruno V, Battaglia G, Copani A, Cespedes VM, Galindo MF, Cena V, Sanchez-Prieto J, Gasparini F, Kuhn R, Flor PJ, Nicoletti F (2001) An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur J Neurosci 13:1469-1478
9. Buck KJ, Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588
10. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550
11. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:219-225
12. Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494-501
13. +-induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 55:620-628
14. Farooqui SM (1994) Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sci 55:1887-1893
15. Ghribi O, Herman MM, Pramoonjago P, Savory J (2003) MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways. J Neuropathol Exp Neurol 62:1144-1153
16. Gosh S, May, Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Ann Rev Immunol 16:225-260
17. Herrero I, Miras-Portugal MT, Sanchez-Prieto J (1998) Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors. J Biol Chem 273:1951-1958
18. Inta I, Paxian S, Maegele I, Zhang W, Pizzi M, Spano PF, Sarnico I, Muhammad S, Herrmann O, Inta D, Baumann B, Liou HC, Schmid RM, Schwaninger M (2006) Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. J Neurosci 26:12896-12903
19. Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 13(Suppl 1):24-34
20. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26(19):5256-5264
21. Kitamura Y, Shimohama S, Akaike A, Taniguchi T (2000) The parkinsonian models: invertebrates to mammals. Japanese J Pharmacol 84:237-243
22. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
23. Lea PM 4th, Faden AI (2003) Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. Drug News Perspect 16:513-522
24. Lipton KP, Singer IP (1993) Advances in our understanding of the mechanisms toxicity of MPTP and related compounds. J Neurochem 61:1191-1206
25. Liu J, Wang CY, O'Brien JS (2001) Prosaptide D5, a retro-inverso 11-mer peptidomimetic, rescued dopaminergic neurons in a model of Parkinson's disease. FASEB J 15:1080-1082
26. Montoliu C, Llansola M, Cucarella C, Grisolia S, Felipo V (1997) Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons. J Pharmacol Exp Ther 281:643-647
27. Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM (1992) Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 89:3859-3863
28. Movsesyan VA, O'Leary DM, Fan L, Bao W, Mullins PG, Knoblach SM, Faden AI (2001) mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 296:41-47
29. Noda Y, Sumino T, Fujisawa Y, Miyata N, Kaiya T, Kohda K (2004) 1-Amino-4-phenyl-1, 2, 3, 6-tetrahydropyridine and 1-amino-4-phenylpyridinium salt, the 1-amino analogues of neurotoxins, MPTP and MPP+, induce apoptosis in PC12 cells: detection of apoptotic cells by comet assay and flow cytometric analysis. In Vivo 18:561-569
30. Pizzi M, Spano P (2006) Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. Eur J Pharmacol 545:22-28
31. Pizzi M, Boroni F, Bianchetti A, Moraitis C, Sarnico I, Benarese M, Goffi F, Valerio A, Spano P (2002a) Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur J Neurosci 16:2342-2350
32. Pizzi M, Goffi F, Boroni F, Benarese M, Perkins SE, Liou HC, Spano P (2002b) Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J Biol Chem 277:20717-20723
33. Pizzi M, Sarnico I, Boroni F, Benarese M, Steimberg N, Mazzoleni G, Dietz GPH, Bähr M, Liou HC, Spano PF (2005) NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ 12:761-772
34. Przedborski S (2005) Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat Disord 11(Suppl 1):S3-S7
35. Richards ML, Sadee W (1986) Human neuroblastoma cell lines as models of catechol uptake. Brain Res 384:132-137
36. Rodriguez-Moreno A, Sistiaga A, Lerma J, Sanchez-Prieto J (1998) Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron 21:1477-1486
37. Sagara Y, Schubert D (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J Neurosci 18:6662-6671
38. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554-559
39. Sistiaga A, Herrero I, Conquet F, Sanchez-Prieto J (1998) The metabotropic glutamate receptor 1 is not involved in the facilitation of glutamate release in cerebrocortical nerve terminals. Neuropharmacology 37:1485-1492
40. Storch A, Ludolph AC, Schwarz J (2004) Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm 111:1267-1286
41. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP, Davis RE, Parker WD (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40:663-671
42. Valerio A, Rizzonelli P, Paterlini M, Moretto G, Knopfel T, Kuhn R, Memo M, Spano P (1997) mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. Neurosci Res 28:49-57
43. Wang C, Sadovova N, Ali HK, Duhart HM, Fu X, Zou X, Patterson TA, Binienda ZK, Virmani A, Paule MG, Slikker W Jr, Ali SF (2007) l-carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture. Neuroscience 144:46-55
44. Yang J, Liu X, Bhalla K, Kim CN, Ibrado A, Cai J (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132